BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

730 related articles for article (PubMed ID: 25132468)

  • 21. Mechanisms of toxicity in C9FTLD/ALS.
    Gendron TF; Belzil VV; Zhang YJ; Petrucelli L
    Acta Neuropathol; 2014 Mar; 127(3):359-76. PubMed ID: 24394885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in the Structure of GGGGCC Repeat RNA Sequence and Its Interaction with Small Molecules and Protein Partners.
    Liu X; Zhao X; He J; Wang S; Shen X; Liu Q; Wang S
    Molecules; 2023 Aug; 28(15):. PubMed ID: 37570771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylation of C9orf72 expansion reduces RNA foci formation and dipeptide-repeat proteins expression in cells.
    Bauer PO
    Neurosci Lett; 2016 Jan; 612():204-209. PubMed ID: 26690922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenic determinants and mechanisms of ALS/FTD linked to hexanucleotide repeat expansions in the C9orf72 gene.
    Wen X; Westergard T; Pasinelli P; Trotti D
    Neurosci Lett; 2017 Jan; 636():16-26. PubMed ID: 27619540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of a family with c9FTD/ALS associated with the GGGGCC repeat expansion in C9ORF72.
    Savica R; Adeli A; Vemuri P; Knopman DS; Dejesus-Hernandez M; Rademakers R; Fields JA; Whitwell J; Jack CR; Lowe V; Petersen RC; Boeve BF
    Arch Neurol; 2012 Sep; 69(9):1164-9. PubMed ID: 22637471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Helicase Unwinds Hexanucleotide Repeat RNA G-Quadruplexes and Facilitates Repeat-Associated Non-AUG Translation.
    Liu H; Lu YN; Paul T; Periz G; Banco MT; Ferré-D'Amaré AR; Rothstein JD; Hayes LR; Myong S; Wang J
    J Am Chem Soc; 2021 May; 143(19):7368-7379. PubMed ID: 33855846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Length of normal alleles of C9ORF72 GGGGCC repeat do not influence disease phenotype.
    Rutherford NJ; Heckman MG; Dejesus-Hernandez M; Baker MC; Soto-Ortolaza AI; Rayaprolu S; Stewart H; Finger E; Volkening K; Seeley WW; Hatanpaa KJ; Lomen-Hoerth C; Kertesz A; Bigio EH; Lippa C; Knopman DS; Kretzschmar HA; Neumann M; Caselli RJ; White CL; Mackenzie IR; Petersen RC; Strong MJ; Miller BL; Boeve BF; Uitti RJ; Boylan KB; Wszolek ZK; Graff-Radford NR; Dickson DW; Ross OA; Rademakers R
    Neurobiol Aging; 2012 Dec; 33(12):2950.e5-7. PubMed ID: 22840558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Mechanisms of Neurodegeneration Related to
    Babić Leko M; Župunski V; Kirincich J; Smilović D; Hortobágyi T; Hof PR; Šimić G
    Behav Neurol; 2019; 2019():2909168. PubMed ID: 30774737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poly(GP) proteins are a useful pharmacodynamic marker for
    Gendron TF; Chew J; Stankowski JN; Hayes LR; Zhang YJ; Prudencio M; Carlomagno Y; Daughrity LM; Jansen-West K; Perkerson EA; O'Raw A; Cook C; Pregent L; Belzil V; van Blitterswijk M; Tabassian LJ; Lee CW; Yue M; Tong J; Song Y; Castanedes-Casey M; Rousseau L; Phillips V; Dickson DW; Rademakers R; Fryer JD; Rush BK; Pedraza O; Caputo AM; Desaro P; Palmucci C; Robertson A; Heckman MG; Diehl NN; Wiggs E; Tierney M; Braun L; Farren J; Lacomis D; Ladha S; Fournier CN; McCluskey LF; Elman LB; Toledo JB; McBride JD; Tiloca C; Morelli C; Poletti B; Solca F; Prelle A; Wuu J; Jockel-Balsarotti J; Rigo F; Ambrose C; Datta A; Yang W; Raitcheva D; Antognetti G; McCampbell A; Van Swieten JC; Miller BL; Boxer AL; Brown RH; Bowser R; Miller TM; Trojanowski JQ; Grossman M; Berry JD; Hu WT; Ratti A; Traynor BJ; Disney MD; Benatar M; Silani V; Glass JD; Floeter MK; Rothstein JD; Boylan KB; Petrucelli L
    Sci Transl Med; 2017 Mar; 9(383):. PubMed ID: 28356511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA Replication Dynamics of the GGGGCC Repeat of the C9orf72 Gene.
    Thys RG; Wang YH
    J Biol Chem; 2015 Nov; 290(48):28953-62. PubMed ID: 26463209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72.
    Murray ME; DeJesus-Hernandez M; Rutherford NJ; Baker M; Duara R; Graff-Radford NR; Wszolek ZK; Ferman TJ; Josephs KA; Boylan KB; Rademakers R; Dickson DW
    Acta Neuropathol; 2011 Dec; 122(6):673-90. PubMed ID: 22083254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration.
    Lagier-Tourenne C; Baughn M; Rigo F; Sun S; Liu P; Li HR; Jiang J; Watt AT; Chun S; Katz M; Qiu J; Sun Y; Ling SC; Zhu Q; Polymenidou M; Drenner K; Artates JW; McAlonis-Downes M; Markmiller S; Hutt KR; Pizzo DP; Cady J; Harms MB; Baloh RH; Vandenberg SR; Yeo GW; Fu XD; Bennett CF; Cleveland DW; Ravits J
    Proc Natl Acad Sci U S A; 2013 Nov; 110(47):E4530-9. PubMed ID: 24170860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unconventional features of C9ORF72 expanded repeat in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
    Vatovec S; Kovanda A; Rogelj B
    Neurobiol Aging; 2014 Oct; 35(10):2421.e1-2421.e12. PubMed ID: 24836899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C9ORF72 GGGGCC Expanded Repeats Produce Splicing Dysregulation which Correlates with Disease Severity in Amyotrophic Lateral Sclerosis.
    Cooper-Knock J; Bury JJ; Heath PR; Wyles M; Higginbottom A; Gelsthorpe C; Highley JR; Hautbergue G; Rattray M; Kirby J; Shaw PJ
    PLoS One; 2015; 10(5):e0127376. PubMed ID: 26016851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Japanese amyotrophic lateral sclerosis patients with GGGGCC hexanucleotide repeat expansion in C9ORF72.
    Konno T; Shiga A; Tsujino A; Sugai A; Kato T; Kanai K; Yokoseki A; Eguchi H; Kuwabara S; Nishizawa M; Takahashi H; Onodera O
    J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):398-401. PubMed ID: 23012445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. All in the Family: Repeats and ALS/FTD.
    Pattamatta A; Cleary JD; Ranum LPW
    Trends Neurosci; 2018 May; 41(5):247-250. PubMed ID: 29703376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural Features of Small Molecules Targeting the RNA Repeat Expansion That Causes Genetically Defined ALS/FTD.
    Ursu A; Wang KW; Bush JA; Choudhary S; Chen JL; Baisden JT; Zhang YJ; Gendron TF; Petrucelli L; Yildirim I; Disney MD
    ACS Chem Biol; 2020 Dec; 15(12):3112-3123. PubMed ID: 33196168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of TOP2 modulates neurodegeneration caused by GGGGCC expanded repeats.
    Jiao B; Wang M; Feng H; Bao H; Zhang F; Wu H; Wang J; Tang B; Jin P; Shen L
    Hum Mol Genet; 2021 May; 30(10):893-901. PubMed ID: 33749734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration.
    Xu Z; Poidevin M; Li X; Li Y; Shu L; Nelson DL; Li H; Hales CM; Gearing M; Wingo TS; Jin P
    Proc Natl Acad Sci U S A; 2013 May; 110(19):7778-83. PubMed ID: 23553836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ALS and FTD linked GGGGCC-repeat containing DNA oligonucleotide folds into two distinct G-quadruplexes.
    Brčić J; Plavec J
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1237-1245. PubMed ID: 27856299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.